[CDNA] CareDx, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization: 94.65 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.85 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CDNA

Refresh chart

Strongest Trends Summary For CDNA

CDNA is in the long-term up 1669% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient?s lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, Californ

Fundamental Ratios
Shares Outstanding18.93 M EPS-1.5 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.49% Sales Growth - Q/Q-9.26% P/E-0.73
P/E To EPS Growth P/S3.31 P/BV2.4 Price/Cash Per Share
Price/Free Cash Flow-23.18 ROA-0.3% ROE-0.47% ROI-0.34%
Current Ratio6.74 Quick Ratio6.62 Long Term Debt/Equity0.41 Debt Ratio0.16
Gross Margin68.21% Operating Margin0.3% Net Profit Margin-0.65% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.93 M Cash From Investing Activities-360 K Cash From Operating Activities-1.01 M Gross Profit4.5 M
Net Profit-2.27 M Operating Profit-1.39 M Total Assets63.28 M Total Current Assets42.3 M
Total Current Liabilities6.28 M Total Debt15.66 M Total Liabilities23.81 M Total Revenue7.22 M
Technical Data
High 52 week40.08 Low 52 week12.1 Last close24.77 Last change-8.39%
RSI28.53 Average true range2.43 Beta0.96 Volume12.77 K
Simple moving average 20 days-21.76% Simple moving average 50 days-28.3% Simple moving average 200 days-17.29%
Performance Data
Performance Week-29.25% Performance Month-38.2% Performance Quart-23.24% Performance Half1.06%
Performance Year68.16% Performance Year-to-date-1.47% Volatility daily5.42% Volatility weekly12.13%
Volatility monthly24.85% Volatility yearly86.09% Relative Volume87.32% Average Volume903.9 K
New High New Low

News

2019-09-17 08:00:00 | CareDx to Participate in the Cantor Fitzgerald Global Healthcare Conference

2019-09-12 08:00:00 | CareDx launches AlloSeq® cfDNA at ESOT 2019

2019-09-12 07:41:23 | Who Has Been Selling CareDx, Inc NASDAQ:CDNA Shares?

2019-09-11 16:01:00 | CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635c4

2019-08-28 08:00:00 | CareDx Acquires XynManagement

2019-08-27 08:00:00 | Chris Cournoyer Joins CareDx Board of Directors

2019-08-22 09:48:48 | AlloSure for Heart Transplant Patients Receives CMS Draft Coverage

2019-08-21 08:00:00 | Fear of Rejection is Transplant Patient’s Top Concern

2019-08-09 13:45:00 | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.- CDNA

2019-08-08 19:16:56 | Caredx Inc CDNA CEO Peter Maag Sold $1.4 million of Shares

2019-08-05 21:30:00 | Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. NASDAQ: CDNA on Behalf of Stockholders and Encourages CareDx Investors to Contact the Firm

2019-08-05 11:40:27 | Edited Transcript of CDNA earnings conference call or presentation 1-Aug-19 8:30pm GMT

2019-08-05 06:06:45 | Is CareDx, Inc's NASDAQ:CDNA CEO Salary Justified?

2019-08-03 09:15:00 | INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc.

2019-08-02 01:31:53 | CareDx, Inc CDNA Q2 2019 Earnings Call Transcript

2019-08-01 16:01:00 | CareDx Reports Second Quarter 2019 Results

2019-07-30 20:10:00 | CDNA INVESTIGATION REMINDER: Hagens Berman Reminds CareDx CDNA Investors to Investigation of Possible Disclosure Violations

2019-07-30 12:32:55 | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.— CDNA

2019-07-30 11:44:45 | CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm

2019-07-26 17:25:00 | Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group

2019-07-25 10:34:02 | CareDx CDNA Reports Next Week: Wall Street Expects Earnings Growth

2019-07-24 19:07:00 | CAREDX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CareDx, Inc. To Contact The Firm

2019-07-23 12:29:39 | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of CareDx Inc.— CDNA

2019-07-22 21:00:00 | Glancy Prongay & Murray LLP Continues Investigation on Behalf of CareDx, Inc. Investors CDNA

2019-07-22 18:22:00 | INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of CareDx, Inc. Investors CDNA

2019-07-17 21:30:00 | Bragar Eagel & Squire, P.C. Is Investigating Hibbett Sports, Pintec Technology, CareDX, and Ideanomics on Behalf of Stockholders and Encourages Investors to Contact the Firm

2019-07-17 15:18:00 | CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of CareDx Inc.-- CDNA

2019-07-16 20:03:00 | CDNA INVESTIGATION ALERT: Hagens Berman Alerts CareDx CDNA Investors to Investigation of Possible Disclosure Violations

2019-07-16 16:51:00 | Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors CDNA

2019-07-16 16:09:00 | Here's Why CareDx Stock Is Sliding Today

2019-07-16 13:51:00 | INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of CareDx, Inc. Investors CDNA

2019-07-11 08:00:00 | CareDx Applauds White House Efforts to Reform America’s Kidney Health System

2019-07-11 04:50:00 | CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long

2019-07-10 17:32:09 | Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others

2019-07-09 10:00:00 | What You Must Know About CareDx, Inc's NASDAQ:CDNA Beta Value

2019-07-02 08:00:00 | Grace Colón succeeds Amy Abernethy on the CareDx Board

2019-06-27 08:00:00 | CareDx Supports Momentum in Medicare Immunosuppressive Medication Legislation

2019-06-26 08:00:00 | US Patent Office Issues New Transplant Patent to CareDx

2019-06-19 18:51:51 | Hedge Funds Have Never Been This Bullish On CareDx, Inc. CDNA

2019-06-10 08:00:00 | CareDx to Participate in Upcoming Conferences

2019-06-03 13:55:24 | Is CareDx, Inc NASDAQ:CDNA Trading At A 41% Discount?

2019-05-29 08:00:00 | CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC

2019-05-22 08:36:52 | CareDx to Participate in Upcoming Conferences

2019-05-14 08:33:18 | CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients

2019-05-09 12:14:00 | Here's Why CareDx Stock Is Rising Today

2019-05-09 01:21:55 | Edited Transcript of CDNA earnings conference call or presentation 8-May-19 8:30pm GMT

2019-05-08 21:48:38 | CareDx, Inc CDNA Q1 2019 Earnings Call Transcript

2019-05-08 18:45:10 | CareDx CDNA Q1 Earnings and Revenues Top Estimates

2019-05-08 17:39:21 | CareDx: 1Q Earnings Snapshot

2019-05-08 16:01:00 | CareDx Reports First Quarter 2019 Results